Citation

Ebeling-Koning NE, Fowler JTJ, DelBianco JD, Surmaitis RM. Cureus 2024; 16(7): e64265.

Copyright

(Copyright © 2024, Curēus)

DOI

10.7759/cureus.64265

PMID

39130979

PMCID

PMC11315443

Abstract

Veterinary medication exposure may result in human toxicity, with approximately 6,000 exposures to veterinary-only medications reported to poison centers in 2022. There is a paucity of literature on the management of poisoned patients secondary to pharmaceuticals intended for equine use. Pergolide is a dopamine and serotonin receptor agonist and is currently approved to treat equine Cushing's disease. It was previously approved in the United States (US) to treat Parkinson's disease in humans; however, it was withdrawn from the market in 2007 due to its association with valvular heart disease. We report two cases of pergolide toxicity in horse owners following unintentional ingestions. Both patients experienced similar clinical presentations resulting from their unintentional pergolide ingestions. Veterinary medication ingestion presents a unique challenge to clinicians as the drug may have limited human toxicity data and/or recommended animal dosing may differ greatly from human dosing. Case reports of human toxicity may assist with anticipating the clinical course and guiding medical decision-making.

Language: en

Keywords

dopamine receptor agonist; equine; pergolide toxicity; unintentional ingestion; veterinary medication exposure